Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses

Canadian Journal of Infectious Diseases

Volumn 14, Issue 1, 2003, Pages 17-27

  Aoki, Fred Y ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antiviral therapy; Herpes simplex virus infection; Prophylaxis

Indexed keywords

ACICLOVIR; FAMCICLOVIR; PENCICLOVIR; VALACICLOVIR;

ANTIVIRAL ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG LABELING; DRUG SAFETY; ERYTHEMA MULTIFORME; GENITAL HERPES; HEALTH CARE COST; HERPES LABIALIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; NEWBORN INFECTION; PROPHYLAXIS; STOMATITIS; TREATMENT PLANNING;

EID: 0037239376     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/984698     Document Type: Article

References (80)

1. de Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother 1983;12(Suppl B):29-37.
2. Soul-Lawton J, Seaber E, On N, et al. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother 1995;39:2759-64.
3. Pue MA, Benet LZ. Pharmacokinetics of famciclovir in man. Antiviral Chem Chemother 1993;4(Suppl 1):47-55.
4. Lewis LD, Fowle ASE, Bittiner SB, et al. Human gastrointestinal absorption of acyclovir from tablet, duodenal infusion and sipped solution. Br J Clin Pharmacol 1986;21:459-62.
5. de Miranda P, Burnette TC, Smith C, et al. Mechanisms of the enhanced oral bioavailability of acyclovir with the prodrug valacyclovir HCl (Valtrex™). 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, October 4 to 7, 1994. (Abst A70)
6. Weller S, Blum MR, Doucette M, et al. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993;54:595-605.
7. Filer CW, Allen GD, Brown TA, et al. Metabolic and pharmacokinetic studies following oral administration of 14C-famciclovir to healthy subjects. Xenobiotica 1994;24:357-68.
8. Elion GB. Mechanism of action and selectivity of acyclovir. Acyclovir Symposium. Am J Med 1982;73:7-13.
9. Vere Hodge RA, Cheng Y-C. The mode of action of penciclovir. Antiviral Chem Chemother 1993;4(Suppl 1):13-24.
10. Darby G, Field HJ, Salisbury SA. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir resistance. Nature 1981;289:81-3.
11. Ehrlich KS, Mills J, Chatis P, et al. Acyclovir-resistant herpes simplex virus infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989;320:293-6.
12. Englund JA, Zimmerman ME, Swierkosz EM, et al. Herpes simplex virus resistant to acyclovir. Ann Intern Med 1990;112:416-22.
13. Amir J, Harel L, Smetana Z, et al. Treatment of herpes simplex gingivostomatitis with acyclovir in children: a randomized double blind placebo controlled study. BMJ 1997;314:1801-3.
14. Aoki FY, Law BJ, Hammond GW, et al. Acyclovir (ACV) suspension for treatment of acute herpes simplex virus (HSV) gingivostomatitis in children: a placebo (PL)-controlled, double-blind trial. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, October 15 to 17, 1993. (Abst 1530)
15. Kuzushima K, Kudo T, Kimura H, et al. Prophylactic oral acyclovir in outbreaks of primary herpes simplex virus Type 1 infection in a closed community. Pediatr 1992;89:379-83.
16. Sullender WM, Arvin AM, Diaz PS, et al. Pharmacokinetics of acyclovir suspension in infants and children. Antimicrob Agents Chemother 1987;31:1722-6.
17. Fiddian AP, Ivanyi L. Topical acyclovir in the management of recurrent herpes labialis. Br J Dermatol 1983;109:321-6.
18. Spruance SL, Schnipper LE, Overall JC Jr, et al. Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis 1982;146:85-90.
19. Fiddian AP, Yeo JM, Stubbins R, et al. Successful treatment of herpes labialis with topical acyclovir. BMJ 1983;286:1699-701.
20. Spruance SL, Stewart JCB, Rome NH, et al. Treatment of recurrent herpes labialis with oral acyclovir. J Infect Dis 1990;161:185-90.
21. Spruance SL, Rea TL, Thoming C, et al. Penciclovir cream for the treatment of herpes simplex labialis. JAMA 1997;277:1374-9.
22. Rooney JF, Straus SE, Mannix ML, et al. Oral acyclovir to suppress frequently recurrent herpes labialis. Ann Intern Med 1983;118:268-72.
23. Thomas RHM, Dodd HJ, Yeo JM, et al. Oral acyclovir in the suppression of recurrent non-genital herpes simplex virus infection. Br J Dermatol 1985;113:731-5.
24. Baker DA, Deeter RG, Redder K, et al. Valacyclovir effective for suppression of recurrent HSV-1 herpes labialis. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, September 17 to 20, 2000. (Abst 464)
25. Schadelin J, Schilt HV, Rohner M. Preventive therapy of herpes labialis associated with trigeminal surgery. Am J Med 1988;85(Suppl 2A):46-8.
26. Spruance SL, Hamill ML, Hoge WS, et al. Acyclovir prevents reactivation of herpes simplex labialis in skiers. JAMA 1988;260:1597-9.
27. Raborn GW, Krueger GG, Hamill ML, et al. Topical acyclovir versus placebo cream in prevention of sun-induced herpes simplex labialis: a randomized blinded trial. J Clin Invest 1990;86:A75. (Abst 462)
28. Gibson JR, Klaber MR, Harver SG, et al. Prophylaxis against herpes labialis with acyclovir cream - a placebo-controlled study. Dermatologica 1986;172:104-7.
29. Niimura M, Nishikawa T. Treatment of eczema herpeticum with oral acyclovir. Am J Med 1988;85(Suppl 2A):49-52.
30. Scholfield JK, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol 1993;128:542-5.
31. Tatnall FM, Scholfield J, Proby C, Leigh IM. A double-blind placebo controlled trial of continuous acyclovir in recurrent erythema multiforme. Br J Dermatol 1991;125(Suppl 38):29. (Abst)
32. Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infections: clinical manifestations, course and complications. Ann Intern Med 1983;98:958-72.
33. Corey L, Benedetti J, Critchlow CW, et al. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy. J Antimicrob Chemother 1983;12(Suppl B):79-88.
34. Mertz GJ, Critchlow CW, Benedetti J, et al. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA 1984;252:1147-51.
35. Wald A, Benedetti J, Davis G, et al. A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections. Antimicrob Agents Chemother 1994;38:174-6.
36. Kinghorn GR, Abeywickreme I, Jeavons M, et al. Efficacy of combined treatment with oral and topical acyclovir in first episode genital herpes. Genitourin Med 1986;67:186-8.
37. Murphy SM, Ruck F, Kitchin VS. Oral famciclovir (FCV) a new antiherpes agent: comparative study with acyclovir in clinic initiated treatment of first episode genital herpes (FGH). EADV/Triaena Congress. Athens, 1991. (Abst)
38. Loveless M, Harris JRW, Sacks SL. Famciclovir in the management of first-episode genital herpes. Infect Dis Clin Prac 1997;6(Suppl 1):S12-S6.
39. Fife KH, Barbarash RA, Rudolph T, et al. Valaciclovir versus acyclovir in the treatment of first episode genital herpes infection. Sex Transm Dis 1997;24:481-6.
40. Corey L, Nahmias AJ, Guinan ME, et al. Trial of topical acyclovir in genital herpes simplex virus infection. N Engl J Med 1982;306:1313-9.
41. Corey L, Benedetti JK, Critchlow CW, et al. Double-blind controlled trial of acyclovir in genital herpes simplex virus infections. Acyclovir Symposium. Am J Med 1982;73:326-34.
42. Reichman RC, Badger GJ, Guinan ME, et al. Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. J Infect Dis 1983;147:336-40.
43. Luby JP, Gnann JW Jr, Alexander WJ, et al. A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo. J Infect Dis 1989;150:1-6.
44. Fiddian AP, Kinghorn GR, Goldmeier D, et al. Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy. J Antimicrob Chemother 1983;12(Suppl B):67-77.
45. Nilsen AE, Assen T, Halsos Am, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet 1982;2:511-3.
46. Salo AP, Lassus A, Hovi T, et al. Double-blind, placebo-controlled, trial of oral acyclovir in recurrent genital herpes. Eur J Sex Trans Dis 1983;1:95-8.
47. Reichman RC, Badger GJ, Mertz GJ, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir. JAMA 1984;251:2103-7.
48. Tyring SK, Douglas JM Jr, Corey L, et al. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. Arch Dermatol 1998;134:185-91.
49. Ruhnek-Forsbeck M, Sandstrom E, Andersson B, et al. Treatment of recurrent genital herpes simplex infection with oral acyclovir. J Antimicrob Chemother 1985;16:621-8.
50. Goldberg LH, Kaufman R, Conant MA, et al. Oral acyclovir for episodic treatment of recurrent genital herpes. J Am Acad Dermatol 1986;15:256-63.
51. Spruance SL, Tyring SK, DeGregorio B, et al. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent genital herpes. Arch Intern Med 1996;156:1729-35.
52. Bodsworth NJ, Crooks RJ, Borelli S, et al. Valaciclovir versus aciclovir in patient-initiated treatment of recurrent genital herpes: a randomized, double-blind trial. Genitourin Med 1997;73:110-6.
53. Sacks SL, Aoki FY, Diaz-Mitoma F, et al. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. JAMA 1996;276:44-9.
54. Leone PA, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes in a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002;34:958-62.
55. Wald A, Carrell D, Remington M, et al. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus Type 2 infection. Clin Infect Dis 2002;34:944-8.
56. Douglas JM, Critchlow C, Benedetti J, et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984;310:1551-6.
57. Strauss SE, Takiff HE, Seidlin M, et al. Suppression of frequently recurring genital herpes. N Engl J Med 1984;310:1545-50.
58. Straus SE, Seidlin M, Takiff HE, et al. Double-blind comparison of weekend and daily regimens of acyclovir for suppression of recurrent genital herpes. Antiviral Res 1986;6:151-9.
59. Sacks SL, Fox R, Levendusky P, et al. Chronic suppression for six months compared with intermittent lesional therapy of recurrent genital herpes using oral acyclovir: effects on lesions and nonlesional prodromes. Sex Transm Dis 1988;15:58-62.
60. Thin RN, Jeffries DJ, Taylor PK, et al. Recurrent genital herpes suppressed by oral acyclovir: a multicentre double blind trial. J Antimicrob Chemother 1985;16:219-26.
61. Mindel A, Weller IVD, Faherty A, et al. Prophylactic oral acyclovir in recurrent genital herpes. Lancet 1984;2:56-9.
62. Kinghorn GR, Jeavons M, Rowland M, et al. Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study. Genitourin Med 1985;61:387-90.
63. Halsos AM, Salo AP, Lassus A, et al. Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled, crossover study. Acta Dermato-Venereologica 1985;65:59-63.
64. Blom I, Bäck O, Egelrud T, et al. Long-term oral acyclovir treatment prevents recurrent genital herpes. Dermatologica 1986;173:220-3.
65. Mertz GJ, Jones CC, Mills J, et al. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA 1988;260:201-6.
66. Baker DA, Blythe JG, Kaufman R, et al. One-year suppression of frequent recurrences of genital herpes with oral acyclovir. Obstet Gynecol 1989;73:84-7.
67. Kroon S, Petersen CS, Andersen LP, et al. Oral acyclovir suppressive therapy in severe recurrent genital herpes. A double-blind, placebo-controlled cross-over study. Danish Med Bulletin 1989;36:298-300.
68. Mostow SR, Mayfield JL, Marr JJ, et al. Suppression of recurrent genital herpes by single daily dosages of acyclovir. The Wellcome International Antiviral Symposium. Am J Med 1988;85(2A):30-33.
69. Reitano M, Tyring S, Lang W, et al. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. J Infect Dis 1998;178:603-10.
70. Goldberg LH, Kaufman R, Kurtz TO, et al. Long-term suppression of recurrent genital herpes with acyclovir. Arch Dermatol 1993;129:582-7.
71. Mindel A, Carney O, Freris AA, et al. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet 1988;i:926-8.
72. Nusinoff Lehrman S, Douglas JM, Corey L, et al. Recurrent genital herpes and suppressive oral acyclovir therapy. Ann Intern Med 1986;104:786-90.
73. Mertz GJ, Loveless MO, Levin MJ, et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. Arch Intern Med 1997;157:343-9.
74. Diaz-Mitoma F, Sibbald GR, Shafran SD, et al. Oral famciclovir for the suppression of recurrent genital herpes. A randomized controlled trial. JAMA 1998;280:887-92.
75. Patel R, Bodworth NJ, Woolley P, et al. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. Genitourin Med 1997;73:105-9.
76. Stray-Pedersen B. Acyclovir in late pregnancy to prevent neonatal herpes simplex. Lancet 1990;336:756.
77. Scott L, Sanchez PJ, Jackson GL, et al. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996;87:69-73.
78. Wald A, Zeh J, Barnum G, et al. Suppression of subclinical shedding of herpes simplex virus Type 2 with acyclovir. Ann Intern Med 1996;124:8-15.
79. Carney O, Ross E, Ikkos G, Mindel A. The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes. Genitourin Med 1993;69:457-9.
80. Rompalo AM, Mertz GJ, Davis LG, et al. Oral acyclovir for treatment of first-episode herpes simplex virus proctitis. JAMA 1988;259:2879-81.